within Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BX02_PerindoprilAndBisoprolol;
model PerindoprilAndBisoprolol 
   extends Pharmacolibrary.Drugs.ATC.C.C09BX02;

  annotation(Documentation(
    info ="<html><body><p>Perindopril and bisoprolol is a fixed-dose combination medication used in the management of hypertension and other cardiovascular indications. Perindopril is an angiotensin-converting enzyme (ACE) inhibitor while bisoprolol is a selective beta-1 blocker. This combination is designed to provide synergistic blood pressure lowering effects and is approved for use today in many countries.</p><h4>Pharmacokinetics</h4><p>No population pharmacokinetic model published for the fixed-dose combination product C09BX02; below parameters are estimates based on known PK properties of individual components in healthy adults.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end PerindoprilAndBisoprolol;
